Lidocaine as an Anesthetic Adjuvant in Liver and Gastric Laparoscopic Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Pain, Postoperative
Interventions
DRUG

Lidocaine Iv

"2% lidocaine or 0.9% physiological saline will be used as placebo, and it will be administered as a bolus during anesthetic induction equivalent to 1.5 mg / kg of lidocaine. After induction, an intravenous infusion will be started at 0.1 ml / kg / h of the study preparation, equivalent to 2mg / kg / h of lidocaine.~20 ml syringe for induction and two 50 ml syringes for anesthetic maintenance containing 2% Lidocaine ."

Trial Locations (1)

17007

Hospital Dr Josep Trueta, Girona

All Listed Sponsors
lead

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

OTHER

NCT04584749 - Lidocaine as an Anesthetic Adjuvant in Liver and Gastric Laparoscopic Surgery | Biotech Hunter | Biotech Hunter